Skip to main content
Circio Holding ASA logo

Circio Holding ASA — Investor Relations & Filings

Ticker · CRNA ISIN · NO0013033795 LEI · 5967007LIEEXZXFYNS31 OL Professional, scientific and technical activities
Open in API
Filings indexed 167 across all filing types
Latest filing 2026-04-29 Regulatory Filings
Country NO Norway
Listing OL CRNA

About Circio Holding ASA

https://www.targovax.com/en/

Circio Holding ASA is a clinical-stage company developing novel medicines based on circular RNA (circRNA) and immunotherapy. The company's core focus is its proprietary circVec platform, a circular RNA expression system designed to enhance the efficacy and durability of gene and cell therapies. Circio's development pipeline is directed towards immuno-oncology, targeting difficult-to-treat solid tumors, and the application of its circRNA technology to address genetic diseases.

Recent filings

Filing Released Lang Actions
Circio announces research collaboration with the Universidad de Santiago de Compostela s TraffikGene project to advance non-viral circVec delivery
Regulatory Filings Classification · 75% confidence The document is a press release announcing a research collaboration between Circio Holding ASA and the Universidad de Santiago de Compostela’s TraffikGene project. It contains no financial results, no AGM materials, no earnings or management discussion, nor details of share transactions, dividends, or M&A. It is a general corporate announcement intended to satisfy regulatory disclosure but does not fall under any more specific category. Therefore it is best classified as a general regulatory filing (RNS).
2026-04-29 English
Circio announces publication of two abstracts selected for presentation at the ASGCT annual meeting - Attachment: ASGCT2026 Circio 2.pdf
Regulatory Filings Classification · 95% confidence The document is a scientific abstract for an oral/poster presentation on a circular RNA platform (circVec) enhancing AAV transgene output, structured with Introduction, Methods, Results, and Conclusion. It has no content related to corporate governance, financial reporting, regulatory notices, or investor communications. It does not correspond to any specialized filing category (e.g., annual report, earnings release, proxy statement). Therefore, it falls into the fallback category for miscellaneous regulatory filings.
2026-04-27 English
Circio announces publication of two abstracts selected for presentation at the ASGCT annual meeting - Attachment: ASGCT2026 Circio 1.pdf
Regulatory Filings Classification · 95% confidence The document is a scientific research abstract on circular RNA-based gene therapy, with no content related to corporate financial reporting, regulatory filings around capital markets, or shareholder communications. It does not match any specific financial filing categories, so it falls into the general fallback category: Regulatory Filings (RNS).
2026-04-27 English
Circio announces publication of two abstracts selected for presentation at the ASGCT annual meeting
Regulatory Filings Classification · 85% confidence The document is a press release announcing the publication of two scientific abstracts selected for presentation at a gene and cell therapy conference. It contains no financial data, no discussion of dividends, capital changes, earnings, management changes, or substantive regulatory filings. It is a general corporate announcement that does not fit any specialized category. Therefore, it falls into the fallback ‘Regulatory Filings’ category for miscellaneous announcements (RNS).
2026-04-27 English
Circio Holding ASA Notice of annual general meeting 2026 - Attachment: Circio Holding ASA AGM Notice 17 04 26.pdf
AGM Information Classification · 100% confidence The document is a detailed notice and agenda for the Annual General Meeting (AGM) of Circio Holding ASA, including proposals for election of board members, auditor changes, approval of annual accounts and reports, remuneration approvals, and other shareholder meeting resolutions. It contains the full agenda and proposed resolutions for the AGM, not just a brief announcement or a report publication notice. The content is typical of AGM Information filings, which include materials shared during the AGM such as meeting agenda, proposals, and voting items. It is not the Annual Report itself, nor a voting results declaration, nor a proxy solicitation. The document length and detail confirm it is the AGM Information (AGM-R) filing type.
2026-04-17 Norwegian
Circio Holding ASA Notice of annual general meeting 2026
Proxy Solicitation & Information Statement Classification · 65% confidence The document is a formal notice of Circio Holding ASA’s upcoming Annual General Meeting, including date, time, location, and reference to the attached agenda and proxy materials (“advance voting, power of attorney”). This fits the Proxy Solicitation & Information Statement category rather than being the AGM materials themselves, an annual or interim report, or a voting results announcement. Therefore, it is classified as PSI (Proxy Solicitation & Information Statement).
2026-04-17 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.